Combination of artesunate and ruxolitinib inhibits T-lymphoblastic leukemia/lymphoma proliferation via the Janus kinase/signal transducer and activator of transcription pathway
Yu‐Pei Yuan(Chinese Academy of Medical Sciences & Peking Union Medical College), Youchao Jia(Affiliated Hospital of Hebei University)
Cited by 0
Related Papers
Tisp40 prevents cardiac ischemia/reperfusion injury through the hexosamine biosynthetic pathway in male mice
|Nature Communications|2023|59